Glassman Wealth Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-36,307
| Closed | -$1.05M | – | 1359 |
|
|
2023
Q4 | $1.05M | Sell |
36,307
-1,528
| -4% | -$46.2K | 0.15% | 48 |
|
|
2023
Q3 | $1.26M | Sell |
37,835
-837
| -2% | -$29.6K | 0.2% | 36 |
|
|
2023
Q2 | $1.42M | Buy |
38,672
+15,984
| +70% | +$622K | 0.23% | 32 |
|
|
2023
Q1 | $926K | Sell |
22,688
-2,800
| -11% | -$121K | 0.16% | 40 |
|
|
2022
Q4 | $1.31M | Buy |
25,488
+904
| +4% | +$43.3K | 0.24% | 32 |
|
|
2022
Q3 | $1.08M | Sell |
24,584
-206
| -0.8% | -$10K | 0.23% | 32 |
|
|
2022
Q2 | $1.3M | Buy |
24,790
+166
| +0.7% | +$8.46K | 0.27% | 32 |
|
|
2022
Q1 | $1.27M | Sell |
24,624
-1,359
| -5% | -$70.5K | 0.23% | 33 |
|
|
2021
Q4 | $1.53M | Buy |
25,983
+1,744
| +7% | +$86.4K | 0.28% | 31 |
|
|
2021
Q3 | $1.04M | Buy |
24,239
+2,571
| +12% | +$114K | 0.22% | 43 |
|
|
2021
Q2 | $849K | Sell |
21,668
-11,380
| -34% | -$443K | 0.18% | 46 |
|
|
2021
Q1 | $1.2M | Sell |
33,048
-1,221
| -4% | -$43.4K | 0.26% | 37 |
|
|
2020
Q4 | $1.26M | Sell |
34,269
-1,605
| -4% | -$58.9K | 0.29% | 34 |
|
|
2020
Q3 | $1.25M | Buy |
35,874
+1,737
| +5% | +$60.9K | 0.34% | 28 |
|
|
2020
Q2 | $1.06M | Buy |
34,137
+10,075
| +42% | +$342K | 0.33% | 28 |
|
|
2020
Q1 | $745K | Buy |
24,062
+2,771
| +13% | +$94.4K | 0.29% | 34 |
|
|
2019
Q4 | $791K | Buy |
21,291
+9,574
| +82% | +$341K | 0.3% | 45 |
|
|
2019
Q3 | $399K | Sell |
11,717
-312
| -3% | -$11.3K | 0.16% | 72 |
|
|
2019
Q2 | $494K | Buy |
12,029
+279
| +2% | +$11.1K | 0.2% | 64 |
|
|
2019
Q1 | $473K | Buy |
11,750
+1,282
| +12% | +$51.3K | 0.21% | 60 |
|
|
2018
Q4 | $434K | Buy |
10,468
+73
| +0.7% | +$3.03K | 0.23% | 58 |
|
|
2018
Q3 | $435K | Sell |
10,395
-107
| -1% | -$4.12K | 0.2% | 56 |
|
|
2018
Q2 | $361K | Sell |
10,502
-864
| -8% | -$29.5K | 0.18% | 59 |
|
|
2018
Q1 | $383K | Buy |
11,366
+1,113
| +11% | +$38.3K | 0.24% | 51 |
|
|
2017
Q4 | $352K | Buy |
10,253
+160
| +2% | +$5.46K | 0.21% | 52 |
|
|
2017
Q3 | $342K | Hold |
10,093
| – | – | 0.22% | 49 |
|
|
2017
Q2 | $322K | Hold |
10,093
| – | – | 0.21% | 53 |
|
|
2017
Q1 | $328K | Sell |
10,093
-31
| -0.3% | -$977 | 0.23% | 46 |
|
|
2016
Q4 | $312K | Buy |
10,124
+168
| +2% | +$5.13K | 0.22% | 46 |
|
|
2016
Q3 | $320K | Buy |
9,956
+116
| +1% | +$3.88K | 0.27% | 41 |
|
|
2016
Q2 | $329K | Sell |
9,840
-6,049
| -38% | -$193K | 0.28% | 34 |
|
|
2016
Q1 | $447K | Hold |
15,889
| – | – | 0.41% | 20 |
|
|
2015
Q4 | $487K | Hold |
15,889
| – | – | 0.44% | 22 |
|
|
2015
Q3 | $474K | Hold |
15,889
| – | – | 0.43% | 25 |
|
|
2015
Q2 | $505K | Hold |
15,889
| – | – | 0.41% | 21 |
|
|
2015
Q1 | $524K | Sell |
15,889
-3,395
| -18% | -$108K | 0.42% | 21 |
|
|
2014
Q4 | $570K | Buy |
+19,284
| New | +$553K | 0.41% | 23 |
|
Other funds holding PFE
Glassman Wealth Services's PFE Position: Q1 2024 in Review
Glassman Wealth Services sold out of Pfizer (PFE) in Q1 2024, closing a stake of 36,307 shares — an estimated $1.05M sold.
Glassman Wealth Services first reported a position in PFE in Q4 2014 and held it in 37 quarters. The position peaked at $1.53M in Q4 2021. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Glassman Wealth Services reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 36,307 Pfizer shares in Q1 2024, an estimated $1.05M.
- Glassman Wealth Services first reported a position in Pfizer in Q4 2014 and held it in 37 quarters.
- Glassman Wealth Services's Pfizer position peaked at $1.53M in Q4 2021.
- 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.